Opportunity
Simpler Grants.gov #FOR-AI-27-017
NIH Solicitation for Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV
Buyer
National Institutes of Health
Posted
June 27, 2025
Respond By
August 19, 2026
Identifier
FOR-AI-27-017
NAICS
541714, 541715
This opportunity from the National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), seeks multidisciplinary research teams to accelerate a cure for Hepatitis B in individuals co-infected with HIV and HBV. - Government Buyer: - National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID) - OEMs and Vendors: - No specific OEMs or vendors are mentioned, as this is a research grant solicitation. - Products/Services Requested: - Multidisciplinary research services focused on: - Mechanisms of HBV persistence and pathogenesis in HIV/HBV co-infection - Biomarker discovery - Identification of drug targets - Development of non-invasive diagnostics - Research teams must leverage samples from existing clinical data and repositories - Unique or Notable Requirements: - Formation of multidisciplinary teams - Use of observational cohorts paired with research teams - Utilization of existing clinical data and sample repositories - Focus on accelerating a cure for Hepatitis B in the context of HIV/HBV co-infection - Funding Details: - Total program funding: $8,000,000 - Expected number of awards: 2 - No product procurement; this is a research grant opportunity.
Description
The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting applications to support multidisciplinary research aimed at accelerating a cure for Hepatitis B in persons living with HIV and HBV. The program focuses on understanding mechanisms of persistence and pathogenesis, discovering biomarkers, identifying drug targets, and developing non-invasive diagnostics. Each award will support an observational cohort with a multidisciplinary team leveraging samples from existing clinical data and repositories. The funding instrument is a cooperative agreement with a total program funding of $8,000,000 and expects to make 2 awards.